부산대학교 도서관

Bahleda, R; Meric-Bernstam, F; Goyal, L; Tran, B; He, Y; Yamamiya, I; Benhadji, KA; Matos, I; Arkenau, H-T

Ann Oncol

Moro-Sibilot, D; Cozic, N; Pérol, M; Mazières, J; Otto, J; Souquet, P J; Bahleda, R; Wislez, M; Zalcman, G; Guibert, S D; Barlési, F; Mennecier, B; Monnet, I; Sabatier, R; Bota, S; Dubos, C; Verriele, V; Haddad, V; Ferretti, G; Cortot, A

Annals of Oncology. Dec2019, Vol. 30 Issue 12, p1985-1991. 7p. 2 Charts, 2 Graphs.

Colevas, A D; Bahleda, R; Braiteh, F; Balmanoukian, A; Brana, I; Chau, N G; Sarkar, I; Molinero, L; Grossman, W; Kabbinavar, F; Fassò, M; O'Hear, C; Powderly, J

Annals of Oncology. Nov2018, Vol. 29 Issue 11, p2247-2253. 7p. 4 Charts, 2 Graphs.

Henon, C; Blay, J -Y; Massard, C; Mir, O; Bahleda, R; Dumont, S; Postel-Vinay, S; Adam, J; Soria, J -C; Cesne, A Le

Annals of Oncology. Aug2019, Vol. 30 Issue 8, p1401-1403. 3p. 1 Graph.

Baldini, C; Younan, N; Alvarez, E Castanon; Bahleda, R; Hollebecque, A; Dhermain, F; Ammari, S; Alentorn, A; Dumont, S; Frenel, J; Stefano, A Di; Bielle, F; Hoang-Xuan, K; Delattre, J; Soria, J; Sanson, M; Idbaih, A; Massard, C; Touat, M

Publisher: Oxford University Press / USA ISSN: 1522-8517

Macaulay, V; Middleton, M; Protheroe, A; Tolcher, A; Dieras, V; Sessa, C; Bahleda, R; Blay, J; LoRusso, P; Mery-Mignard, D; Soria, J

Annals of Oncology. 24:784-791

Ngo C; Department of Biology and Pathology, Gustave Roussy, Villejuif, France; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France.; Grinda T; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Boilève A; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Levy A; Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.; Le Pechoux C; Department of Radiation Oncology, Gustave Roussy, Villejuif, France.; Haddag L; Department of Radiology, Gustave Roussy, Villejuif, France.; Valent A; Department of Biology and Pathology, Gustave Roussy, Villejuif, France.; Lazure T; Department of Pathology, Bicêtre Hospital, Université Paris-Saclay, Le Kremlin-Bicêtre, France.; Briand S; Department of Orthopaedics and Traumatology, Bicêtre Hospital, Université Paris-Saclay, Le Kremlin-Bicêtre, France.; Honoré C; Department of Surgery, Gustave Roussy, Villejuif, France.; Faron M; Department of Surgery, Gustave Roussy, Villejuif, France.; Mir O; Department of Ambulatory Cancer Care, Gustave Roussy, Villejuif, France.; Bahleda R; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Verret B; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.; Le Cesne A; Department of Cancer Medicine, Gustave Roussy, Villejuif, France. Electronic address: axel.lecesne@gustaveroussy.fr.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Nassif EF; Cancer Medicine Department, Centre Léon Bérard, Lyon, France. Electronic address: https://twitter.com/NassifElise.; Blay JY; Cancer Medicine Department, Centre Léon Bérard, Lyon, France. Electronic address: https://twitter.com/jeanyvesblay.; Massard C; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. Electronic address: https://twitter.com/drcmassard.; Dufresne A; Cancer Medicine Department, Centre Léon Bérard, Lyon, France.; Brahmi M; Cancer Medicine Department, Centre Léon Bérard, Lyon, France.; Cassier P; Early Phase Trial Unit, Centre Léon Bérard, Lyon, France.; Ray-Coquard I; Cancer Medicine Department, Centre Léon Bérard, Lyon, France. Electronic address: https://twitter.com/CoquardRay.; Pautier P; Cancer Medicine Department, Gustave Roussy, Villejuif, France.; Leary A; Cancer Medicine Department, Gustave Roussy, Villejuif, France.; Sunyach MP; Radiation Oncology Department, Centre Léon Bérard, Lyon, France.; Bahleda R; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France.; Levy A; Radiation Oncology Department, Gustave Roussy, Villejuif, France.; Le Pechoux C; Radiation Oncology Department, Gustave Roussy, Villejuif, France.; Honoré C; Surgical Oncology Department, Gustave Roussy, Villejuif, France.; Mir O; Ambulatory Cancer Care Department, Gustave Roussy, Villejuif, France.; Le Cesne A; International Department, Gustave Roussy, Villejuif, France. Electronic address: axel.lecesne@gustaveroussy.fr.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Jung, J; Lee, JS; Dickson, MA; Schwartz, GK; le Cesne, A; Varga, A; Bahleda, R; Wagner, AJ; Choy, E; de Jonge, Maja; Light, M; Rowley, S; Mace, S; Watters, J

Nat Commun
Nature Communications, Vol 7, Iss 1, Pp 1-7 (2016)

Hollebecque A; Deutsch E; Massard C; Gomez-Roca C; Bahleda R; Ribrag V; Bourgier C; Lazar V; Lacroix L; Gazzah A; Varga A; de Baere T; Beier F; Kroesser S; Trang K; Zenke FT; Klevesath M; Soria JC

Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

Tran, B; Meric-Bernstam, F; Arkenau, H-T; Bahleda, R; Kelley, R K; Hierro, C; Ahn, D; Zhu, A; Javle, M; Winkler, R

Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.

Bernard-Tessier, A; Baldini, C; Alvarez, E Castanon; Ammari, S; Romano, P Martin; Champiat, S; Hollebecque, A; Postel-Vinay, S; Varga, A; Bahleda, R

Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.

Vozy, A; Simonaggio, A; Auclin, E; Mezquita, L; Baldini, C; Martin-Romano, P; Pistilli, B; Gazzah, A; Bahleda, R; Ribrag, V

Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.

Herin H; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.; Aspeslagh S; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.; Castanon E; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.; Dyevre V; Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, Villejuif, F-94805, France.; Marabelle A; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.; Varga A; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.; Postel Vinay S; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.; Michot JM; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.; Ribrag V; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.; Gazzah A; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.; Bahleda R; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.; Mir O; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.; Massard C; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.; Hollebecque A; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.; Soria JC; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France.; Baldini C; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France. Electronic address: capucine.baldini@gustaveroussy.fr.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Hartl, DM; Ferté, C; Loriot, Y; Gomez Roca, C; Bahleda, R; Moldovan, C; Mir, O; Soria, JC

Investigational New Drugs (INVEST NEW DRUGS), Dec2010; 28(6): 884-886. (3p)

Hollebecque A; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France. Electronic address: Antoine.HOLLEBECQUE@gustaveroussy.fr.; Bahleda R; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France.; Faivre L; Gustave Roussy, Université Paris-Saclay, Service de biostatistique et d'épidémiologie, Villejuif, F-94805, France.; Adam J; Gustave Roussy, Université Paris-Saclay, Département de biologie et pathologie médicales, Villejuif, F-94805, France.; Poinsignon V; Gustave Roussy, Université Paris-Saclay, Pharmacology and Drug analysis department, Villejuif, F-94805, France.; Paci A; Gustave Roussy, Université Paris-Saclay, Pharmacology and Drug analysis department, Villejuif, F-94805, France.; Gomez-Roca C; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France.; Thery JC; University Hospital Pitié Salpêtrière, Department of Medical Oncology, University Pierre and Marie Curie, Paris, France.; Le Deley MC; Gustave Roussy, Université Paris-Saclay, Service de biostatistique et d'épidémiologie, Villejuif, F-94805, France.; Varga A; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France.; Gazzah A; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France.; Ileana E; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France.; Gharib M; University Hospital Pitié Salpêtrière, Department of Medical Oncology, University Pierre and Marie Curie, Paris, France.; Angevin E; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France.; Malekzadeh K; Gustave Roussy, Université Paris-Saclay, Service de biostatistique et d'épidémiologie, Villejuif, F-94805, France.; Massard C; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France.; Soria JC; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France.; Spano JP; University Hospital Pitié Salpêtrière, Department of Medical Oncology, University Pierre and Marie Curie, Paris, France.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Soria JC; Drug Development Department at Gustave Roussy Cancer Campus, University Paris-Sud, Paris, France soria@igr.fr.; Gan HK; Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Australia.; School of Cancer Medicine, Latrobe University, Melbourne, Australia.; Blagden SP; Imperial College, Hammersmith Hospital, London.; Plummer R; Northern Centre for Cancer Care, Newcastle.; Arkenau HT; Sarah Cannon Research Institute, London.; Ranson M; University of Manchester, Christie Hospital, Manchester.; Evans TR; University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.; Zalcman G; Early Phases Clinical Trials Unit at Caen University Hospital, Caen, France.; Bahleda R; Drug Development Department at Gustave Roussy Cancer Campus, University Paris-Sud, Paris, France.; Hollebecque A; Drug Development Department at Gustave Roussy Cancer Campus, University Paris-Sud, Paris, France.; Lemech C; Sarah Cannon Research Institute, London.; Dean E; University of Manchester, Christie Hospital, Manchester.; Brown J; University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.; Gibson D; GlaxoSmithKline, Research Triangle Park, NC and Upper Providence, Collegeville, USA.; Peddareddigari V; GlaxoSmithKline, Research Triangle Park, NC and Upper Providence, Collegeville, USA.; Murray S; GlaxoSmithKline, Research Triangle Park, NC and Upper Providence, Collegeville, USA.; Nebot N; GlaxoSmithKline, Research Triangle Park, NC and Upper Providence, Collegeville, USA.; Mazumdar J; GlaxoSmithKline, Research Triangle Park, NC and Upper Providence, Collegeville, USA.; Swartz L; GlaxoSmithKline, Research Triangle Park, NC and Upper Providence, Collegeville, USA.; Auger KR; GlaxoSmithKline, Research Triangle Park, NC and Upper Providence, Collegeville, USA.; Fleming RA; GlaxoSmithKline, Research Triangle Park, NC and Upper Providence, Collegeville, USA.; Singh R; GlaxoSmithKline, Research Triangle Park, NC and Upper Providence, Collegeville, USA.; Millward M; School of Medicine and Pharmacology, University of Western Australia, Sir Charles Gairdner Hospital, Perth, Australia.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Michot JM; Department of Medicine Oncology, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France; Internal Medicine and Clinical Immunology Department, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Bicêtre, F-94275 Le Kremlin Bicêtre, France. Electronic address: jean-marie.michot@gustaveroussy.fr.; Bigenwald C; Department of Medicine Oncology, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France.; Champiat S; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France.; Collins M; Gastroenterology Department, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Bicêtre, F-94275 Le Kremlin Bicêtre, France; Université Paris Sud 11, F-94275 Le Kremlin-Bicêtre, France.; Carbonnel F; Gastroenterology Department, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Bicêtre, F-94275 Le Kremlin Bicêtre, France; Université Paris Sud 11, F-94275 Le Kremlin-Bicêtre, France.; Postel-Vinay S; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France.; Berdelou A; Department of Medicine Oncology, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France.; Varga A; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France.; Bahleda R; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France.; Hollebecque A; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France.; Massard C; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France.; Fuerea A; Department of Medicine Oncology, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France.; Ribrag V; Department of Medicine Oncology, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France.; Gazzah A; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France.; Armand JP; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France.; Amellal N; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France.; Angevin E; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France.; Noel N; Internal Medicine and Clinical Immunology Department, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Bicêtre, F-94275 Le Kremlin Bicêtre, France; Université Paris Sud 11, F-94275 Le Kremlin-Bicêtre, France; CEA, DSV/iMETI, Division of Immunovirology, IDMIT, F-92265 Fontenay-aux-Roses, France; INSERM, U1184, Center for Immunology of Viral Infections and Autoimmune Diseases, F-94276 Le Kremlin-Bicêtre, France.; Boutros C; Department of Medicine Oncology, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France; Internal Medicine and Clinical Immunology Department, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Bicêtre, F-94275 Le Kremlin Bicêtre, France.; Mateus C; Department of Medicine Oncology, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France; Internal Medicine and Clinical Immunology Department, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Bicêtre, F-94275 Le Kremlin Bicêtre, France.; Robert C; Department of Medicine Oncology, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France; Internal Medicine and Clinical Immunology Department, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Bicêtre, F-94275 Le Kremlin Bicêtre, France.; Soria JC; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France.; Marabelle A; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France.; Lambotte O; Internal Medicine and Clinical Immunology Department, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Bicêtre, F-94275 Le Kremlin Bicêtre, France; Université Paris Sud 11, F-94275 Le Kremlin-Bicêtre, France; CEA, DSV/iMETI, Division of Immunovirology, IDMIT, F-92265 Fontenay-aux-Roses, France; INSERM, U1184, Center for Immunology of Viral Infections and Autoimmune Diseases, F-94276 Le Kremlin-Bicêtre, France.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Kossai M; Departments of Pathology.; Duchemann B; Departments Gustave Roussy, Villejuif, France; Avicenne Hospital, Paris, France.; Boutros C; Departments of Cancer Medicine.; Caramella C; Departments of Radiology.; Hollebecque A; Departments of Drug Development (DITEP).; Angevin E; Departments of Drug Development (DITEP).; Gazzah A; Departments of Drug Development (DITEP).; Bahleda R; Departments of Drug Development (DITEP).; Ileana E; Departments of Drug Development (DITEP).; Massard C; Departments of Drug Development (DITEP).; Vielh P; Departments of Pathology.; Soria JC; Departments of Drug Development (DITEP).; Besse B; Departments of Cancer Medicine; Departments Paris-Sud University, Kremlin-Bicêtre. Electronic address: benjamin.besse@gustaveroussy.fr.

Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Deutsch E; Department of Radiation Oncology; Drug Development Department (DITEP), Gustave Roussy, Paris-Sud University, Villejuif; Paris-Sud University, Kremlin-Bicêtre Medical University, DHU TORINO, SIRIC SOCRATES, LABEX LERMIT; INSERM 1030 Molecular Radiotherapy, Cancer research institute, Villejuif. Electronic address: eric.deutsch@gustaveroussy.fr.; Le Péchoux C; Department of Radiation Oncology; Institut d'Oncologie Thoracique (IOT).; Faivre L; Departments of Biostatistics.; Rivera S; Department of Radiation Oncology; Drug Development Department (DITEP), Gustave Roussy, Paris-Sud University, Villejuif.; Tao Y; Department of Radiation Oncology; Drug Development Department (DITEP), Gustave Roussy, Paris-Sud University, Villejuif.; Pignon JP; Departments of Biostatistics.; Angokai M; Departments of Biostatistics.; Bahleda R; Drug Development Department (DITEP), Gustave Roussy, Paris-Sud University, Villejuif.; Deandreis D; Nuclear Medicine, Gustave Roussy, Villejuif.; Angevin E; Drug Development Department (DITEP), Gustave Roussy, Paris-Sud University, Villejuif.; Hennequin C; Department of Radiation Oncology, Saint Louis Hospital, Paris.; Besse B; Institut d'Oncologie Thoracique (IOT); Department of Medicine, Gustave Roussy, Villejuif, France.; Levy A; Department of Radiation Oncology; Drug Development Department (DITEP), Gustave Roussy, Paris-Sud University, Villejuif; INSERM 1030 Molecular Radiotherapy, Cancer research institute, Villejuif; Institut d'Oncologie Thoracique (IOT).; Soria JC; Drug Development Department (DITEP), Gustave Roussy, Paris-Sud University, Villejuif; Paris-Sud University, Kremlin-Bicêtre Medical University, DHU TORINO, SIRIC SOCRATES, LABEX LERMIT; Institut d'Oncologie Thoracique (IOT).

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE